Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Search
English
  1. OncologyPRO
  2. Oncology in practice
  3. Palliative and Supportive care
  4. EGFRI-Related Skin Toxicity
  5. Healthcare Professionals
  6. Prophylaxis and Treatment
  7. Reactive Management

Reactive Management for Trichomegaly/Hypertrichosis Grade 1-2

General Recommendations

Trichomegaly / Hypertrichosis may occur; prophylactic measures are unavailable.

Treatment

Any grade: trimming of the eyelashes to avoid conjunctivitis.
Eflornithine cream for vellus hair Hypertrichosis.
In severe cases, laser epilation may be useful.1

Products

  • Eflornithine cream.

EGFRI Treatment

Continue with the selected EGFRI-treatment regimen. Continue with/withold the selected EGFRI-treatment regimen, as recommended in the current and relevant SmPC and according to the patient’s condition. 2,3,4,5,6

References

1Segaert S et al. Eur J Cancer 2009; 45(Suppl 1): 295-308.
2European Medicine Agency. Tarceva® (erlotinib) Summary of Product Characteristics 2009.
3European Medicine Agency. Iressa® (gefitinib) Summary of Product Characteristics 2009.
4European Medicine Agency. Erbitux® (cetuximab) Summary of Product Characteristics 2009.
5European Medicine Agency. Vectibix® (panitumumab) Summary of Product Characteristics 2009.
6European Medicine Agency. Tyverb® (lapatinib) Summary of Product Characteristics 2010. 

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings